RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-7.01%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$880M
AUM Growth
+$880M
(-13%)
Cap. Flow
-$43M
Cap. Flow
% of AUM
-4.88%
Top 10 Holdings %
Top 10 Hldgs %
31.67%
Holding
96
New
7
Increased
27
Reduced
39
Closed
10
Top Buys
| 1 |
Abbott
ABT
|
$8.69M |
| 2 |
Boston Scientific
BSX
|
$8.01M |
| 3 |
Humana
HUM
|
$7.72M |
| 4 |
Thermo Fisher Scientific
TMO
|
$7.25M |
| 5 |
Royalty Pharma
RPRX
|
$6.31M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$16.1M |
| 2 |
Centene
CNC
|
$15.7M |
| 3 |
Eli Lilly
LLY
|
$10.9M |
| 4 |
McKesson
MCK
|
$10.4M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$8.57M |
Sector Composition
| 1 | Healthcare | 98.45% |
| 2 | Industrials | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
51
DELISTED
Immunogen Inc
IMGN
| $5.4M | 0.61% |
1,200,000
-225,000
| -16% | -$1.01M |
|
52
Immunocore
IMCR
$1.78B
| $5.22M | 0.59% |
140,000
-30,472
| -18% | -$1.14M |
|
53
Alkermes
ALKS
$4.95B
| $4.47M | 0.51% |
150,000
-30,000
| -17% | -$894K |
|
54
Edwards Lifesciences
EW
$47.7B
| $4.28M | 0.49% |
45,000
-20,000
| -31% | -$1.9M |
|
55
Align Technology
ALGN
$9.59B
| $4.26M | 0.48% |
18,000
-12,000
| -40% | -$2.84M |
|
|
AERI
56
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.22M | 0.48% |
562,350
-26,850
| -5% | -$201K |
|
57
HCA Healthcare
HCA
$95.4B
| $4.2M | 0.48% |
+25,000
| New | +$4.2M |
|
58
NovoCure
NVCR
$1.35B
| $4.17M | 0.47% |
60,000
-9,700
| -14% | -$674K |
|
59
Glaukos
GKOS
$5.42B
| $4.09M | 0.46% |
89,991
-15,300
| -15% | -$695K |
|
60
Allogene Therapeutics
ALLO
$249M
| $3.99M | 0.45% |
+350,000
| New | +$3.99M |
|
|
MYOV
61
DELISTED
Myovant Sciences Ltd.
MYOV
| $3.85M | 0.44% |
310,000
+60,700
| +24% | +$754K |
|
62
Guardant Health
GH
$8.11B
| $3.83M | 0.44% |
95,000
| – | – |
|
63
MeiraGTx Holdings
MGTX
$590M
| $3.79M | 0.43% |
500,000
| – | – |
|
64
Agilon Health
AGL
$497M
| $3.6M | 0.41% |
+165,000
| New | +$3.6M |
|
65
Exact Sciences
EXAS
$9.33B
| $2.99M | 0.34% |
76,000
| – | – |
|
|
ONEM
66
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $2.94M | 0.33% |
375,250
| – | – |
|
67
Sangamo Therapeutics
SGMO
$161M
| $2.9M | 0.33% |
700,000
-61,429
| -8% | -$254K |
|
68
Teladoc Health
TDOC
$1.37B
| $2.82M | 0.32% |
85,000
-7,000
| -8% | -$232K |
|
69
Outset Medical
OM
$245M
| $2.68M | 0.3% |
+180,000
| New | +$2.68M |
|
|
VRAY
70
DELISTED
ViewRay, Inc.
VRAY
| $2.65M | 0.3% |
1,000,000
+265,000
| +36% | +$702K |
|
71
Progyny
PGNY
$2.02B
| $2.62M | 0.3% |
90,000
-10,000
| -10% | -$291K |
|
72
Health Catalyst
HCAT
$228M
| $2.61M | 0.3% |
180,000
| – | – |
|
73
Intellia Therapeutics
NTLA
$1.26B
| $2.59M | 0.29% |
50,000
| – | – |
|
74
Nkarta
NKTX
$149M
| $2.46M | 0.28% |
+200,000
| New | +$2.46M |
|
|
ISEE
75
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.41M | 0.27% |
250,000
-10,000
| -4% | -$96.2K |
|